Lexicon Pharmaceuticals Inc.

10/02/2022 | Press release | Distributed by Public on 10/02/2022 11:16

New Analysis of Soloist-WHF Trial Underscores Sotagliflozin’s Effect on Reducing Recurrent Heart Failure Events